CPAP therapy improves surrogate, intermediate, and functional cardiovascular outcomes in adults with obstructive sleep apnea, particularly blood pressure, left ventricular function, and sympathetic activity.
This umbrella review of 38 systematic reviews and meta-analyses found that CPAP therapy was associated with significant reductions in systolic blood pressure (MD -4.8 mmHg) and diastolic blood pressure (MD -3.0 mmHg), improvements in left ventricular ejection fraction (MD 3.27) and diastolic function (WMD 0.22), and reduced sympathetic activity (noradrenaline SMD -1.10). However, the certainty of evidence ranged from low to moderate, and no consistent reduction in major adverse cardiovascular events or mortality was demonstrated.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
CPAP therapy improves surrogate, intermediate, and functional cardiovascular outcomes in adults with obstructive sleep apnea, particularly blood pressure, left ventricular function, and sympathetic activity. The current body of evidence comprises 1 study and 1 meta-analysis. EvidenceHub rates the overall confidence at 49/100 (low).
The Claim
CPAP therapy improves surrogate, intermediate, and functional cardiovascular outcomes in adults with obstructive sleep apnea, particularly blood pressure, left ventricular function, and sympathetic activity.
This conclusion is most relevant to: Adults with obstructive sleep apnea (OSA), including those with heart failure.
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸Effects of Continuous Positive Airway Pressure on Surrogate, Intermediate, and Functional Cardiovascular Outcomes in Obstructive Sleep Apnea: An Umbrella Review of Systematic Reviews and Meta-Analyses. (Medicina (Kaunas, Lithuania), 2026) — This umbrella review of 38 systematic reviews and meta-analyses found that CPAP therapy was associated with significant reductions in systolic blood pressure (MD -4.8 mmHg) and diastolic blood pressure (MD -3.0 mmHg), improvements in left ventricular ejection fraction (MD 3.27) and diastolic function (WMD 0.22), and reduced sympathetic activity (noradrenaline SMD -1.10). However, the certainty of evidence ranged from low to moderate, and no consistent reduction in major adverse cardiovascular events or mortality was demonstrated.
How It Works
The proposed biological pathway:
- ▸CPAP prevents upper airway collapse during sleep, reducing apneas and hypopneas
- ▸Improved oxygenation and reduced intermittent hypoxia
- ▸Decreased sympathetic nervous system activation and reduced catecholamine levels
- ▸Reduced afterload and improved cardiac function, leading to lower blood pressure and better ventricular performance
Who Might Benefit
Evidence fit by population:
- ▸Adults with obstructive sleep apnea (OSA), including those with heart failure
Recommended Dose
N/A
Limitations & Caveats
Important context when interpreting this evidence:
- ▸Certainty of evidence ranged from low to moderate due to heterogeneity and methodological limitations
- ▸Methodological confidence of included reviews was predominantly moderate, low, or critically low (AMSTAR 2)
- ▸Insufficient evidence to demonstrate consistent reduction in major adverse cardiovascular events or cardiovascular mortality
Frequently Asked Questions
Does CPAP reduce blood pressure in OSA patients?▼
Yes, CPAP was associated with a mean reduction of 4.8 mmHg in systolic and 3.0 mmHg in diastolic blood pressure, along with improvements in 24-hour ambulatory blood pressure.
What is the effect of CPAP on heart function?▼
CPAP improved left ventricular ejection fraction by a mean difference of 3.27 and left ventricular diastolic function (WMD 0.22), particularly in patients with heart failure.
Does CPAP reduce sympathetic nervous system activity?▼
Yes, CPAP reduced circulating noradrenaline levels with a standardized mean difference of -1.10, indicating decreased sympathetic activity.
Is CPAP effective in reducing cardiovascular mortality?▼
Current evidence is insufficient to demonstrate a consistent reduction in major adverse cardiovascular events or cardiovascular mortality; longer-term high-quality trials are needed.
References
- 1.Bunjaku J, Rashiti P, Lama A, Bunjaku G, Koliqi R. “Effects of Continuous Positive Airway Pressure on Surrogate, Intermediate, and Functional Cardiovascular Outcomes in Obstructive Sleep Apnea: An Umbrella Review of Systematic Reviews and Meta-Analyses..” Medicina (Kaunas, Lithuania), 2026. PMID: 42654353 DOI: 10.3390/medicina62081456